World Trade Systems PLC R&D, Product Diversification (7351F)
22 5월 2017 - 3:00PM
UK Regulatory
TIDMWTS
RNS Number : 7351F
World Trade Systems PLC
19 May 2017
World Trade Systems PLC
19(th) May 2017
WORLD TRADE SYSTEMS PLC ("WTS plc")
WTS plc announces that it has entered into a memorandum of
understanding ("MOU") in connection with a commercial cooperation
agreement with an international company that aligns with the
overarching goals and vision of WTS plc. The Board of WTS plc
believes that this will result in the expansion of the business of
WTS China by diversifying its product range and extending its
market reach.
R&D and market distribution co-operation with Naturemed GmbH
("Naturemed")
WTS plc has entered into an MOU with 'Naturemed', an
international company based in Remscheid, Germany.
Naturemed was established in October 2016 by Dr.Dahlia-Rosa
Smolczyk and Mr. Diether Klingelnberg. Dr.Dahlia-Rosa Smolczyk is
the company's current managing director. She is a qualified Medical
doctor specialized in Neurosurgery and has a number of years of
experience in sales and distribution of products to pharmaceutical
companies.
Mr. Diether Klingelnberg, is the founder and investor of
Naturemed, who has been involved in the development of natural
medicine over the last 10 years. Mr. Klingelnberg's associated
companies have done substantial research in well-known clinics with
medical professors especially in the fields of arthrosis and
osteoporosis.
Naturemed is engaged in developing vital medicine abstract from
cells for enhancing strength and wellbeing. Since October 2016
Naturemed has developed a promising product for arthrosis and
osteoporosis in the over-the-counter drug (OTC) and pharmacy field
with excellent results. Naturemed has established three tested,
effective cell based product lines including natural protein,
vitamin, mineral capsules, personal hygiene and skin care
cream.
WTS plc believes that through close collaboration with Naturemed
it can pool R&D and market knowledge to help both companies
achieve their shared visions of improving health and life quality
of people by distributing new healthcare and cell based products in
the Asian market.
WTS plc will seek any necessary authorities in due course.
For more information, please contact the following:
World Trade Systems plc
Mr. Shao Chen, Vice Chairman, shaochen@wtscn.com
Mr. AKM Ismail, Executive Director (Finance),
akm.ismail@gmail.com
Information on WTS plc
WTS plc is a health food products company that develops,
manufactures and distributes health food products targeted at
mid/high end consumers. Having previously had no business
activities for a number of years, the Company began its current
business activities in July of 2016 and is in the process of
applying for a re-listing of its shares on the Standard Segment of
the Official List of the Financial Conduct Authority.
Information on WTS China
Based on its expertise in the Chinese health food industry, with
a focused product strategy, a progressive marketing plan, and in
depth understanding of consumer trends, WTS China aims to become a
comprehensive health food solution provider. WTS China is located
in Suzhou, Jiangsu Province, in the central part of eastern
China.
WTS China's current health drinks use collagen and other natural
ingredients aimed at providing consumers with healthy food
supplements containing nutrients which aim to support the body's
immune system, improve digestion, lower cholesterol and blood
pressure and promote healthier organ functions, smoother and more
elastic skin and better complexion. WTS China is active in R&D
developing additional products.
WTS China's vision is to become a leading player in distributing
many high quality health food products throughout China.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGRKMGMKNLZGNZM
(END) Dow Jones Newswires
May 22, 2017 02:00 ET (06:00 GMT)
World Trade Systems (LSE:WTS)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
World Trade Systems (LSE:WTS)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024